ArticleNature medicine2024

Author Correction: Tirzepatide after intensive lifestyle intervention in adults with overweight or obesity: the SURMOUNT-3 phase 3 trial.

Thomas A Wadden et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.